Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -1.39M | 2.08M | 2.94M | 2.57M | 8.18M |
| Total Depreciation and Amortization | 95.60K | 122.80K | 119.20K | 116.50K | 116.40K |
| Total Amortization of Deferred Charges | 142.60K | 253.60K | 363.40K | 467.10K | 537.40K |
| Total Other Non-Cash Items | 263.40K | -4.13M | -5.20M | -5.10M | -10.76M |
| Change in Net Operating Assets | 341.80K | 1.26M | 1.28M | 1.34M | 1.16M |
| Cash from Operations | -550.00K | -417.80K | -498.90K | -596.90K | -762.30K |
| Capital Expenditure | -- | 0.00 | 0.00 | 0.00 | -58.00K |
| Sale of Property, Plant, and Equipment | 83.60K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.70K | 85.20K | 100.00K | 99.30K | 85.30K |
| Cash from Investing | 117.30K | 85.20K | 100.00K | 99.30K | 27.30K |
| Total Debt Issued | 909.00K | 1.02M | 1.04M | 1.18M | 1.33M |
| Total Debt Repaid | -476.20K | -682.30K | -653.00K | -684.50K | -684.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 432.80K | 332.70K | 388.60K | 490.70K | 644.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 0.00 | -10.40K | -6.90K | -90.90K |